Tianjin Ringpu Bio Tech Asset Resilience Ratio

Latest as of March 2026: 14.27%

Tianjin Ringpu Bio Tech asset resilience ratio. Tianjin Ringpu Bio Tech (300119) has an Asset Resilience Ratio of 14.27% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tianjin Ringpu Bio Tech (300119) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.11 Billion

≈ $162.89 Million USD Cash + Short-term Investments

Total Assets

CN¥7.80 Billion

≈ $1.14 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of Tianjin Ringpu Bio Tech (2015–2025)

Asset resilience ratio of Tianjin Ringpu Bio Tech from 2015 to 2025. This chart shows how Tianjin Ringpu Bio Tech's Asset Resilience Ratio has changed over time. Read how much debt does Tianjin Ringpu Bio Tech carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Ringpu Bio Tech's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300119 total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.11 Billion	14.27%
Total Liquid Assets	CN¥1.11 Billion	14.27%

Asset Resilience Insights

Moderate Liquidity: Tianjin Ringpu Bio Tech has 14.27% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Tianjin Ringpu Bio Tech Industry Peers by Asset Resilience Ratio

Compare Tianjin Ringpu Bio Tech's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Tianjin Ringpu Bio Tech Asset Resilience Ratio by Year (2015–2025)

Tianjin Ringpu Bio Tech asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Tianjin Ringpu Bio Tech.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	13.62%	CN¥1.04 Billion ≈ $152.58 Million	CN¥7.66 Billion ≈ $1.12 Billion	-4.60pp
2024-12-31	18.22%	CN¥1.45 Billion ≈ $212.36 Million	CN¥7.97 Billion ≈ $1.17 Billion	-1.24pp
2023-12-31	19.46%	CN¥1.28 Billion ≈ $187.80 Million	CN¥6.60 Billion ≈ $965.19 Million	-5.12pp
2022-12-31	24.58%	CN¥1.50 Billion ≈ $219.62 Million	CN¥6.11 Billion ≈ $893.54 Million	+14.42pp
2021-12-31	10.15%	CN¥577.88 Million ≈ $84.56 Million	CN¥5.69 Billion ≈ $832.74 Million	-0.10pp
2020-12-31	10.25%	CN¥399.83 Million ≈ $58.51 Million	CN¥3.90 Billion ≈ $570.58 Million	-0.56pp
2019-12-31	10.81%	CN¥385.29 Million ≈ $56.38 Million	CN¥3.56 Billion ≈ $521.42 Million	+1.57pp
2018-12-31	9.25%	CN¥277.21 Million ≈ $40.56 Million	CN¥3.00 Billion ≈ $438.77 Million	+2.14pp
2017-12-31	7.11%	CN¥207.80 Million ≈ $30.41 Million	CN¥2.92 Billion ≈ $427.90 Million	-2.54pp
2016-12-31	9.64%	CN¥263.60 Million ≈ $38.57 Million	CN¥2.73 Billion ≈ $399.95 Million	+6.69pp
2015-12-31	2.95%	CN¥69.30 Million ≈ $10.14 Million	CN¥2.35 Billion ≈ $343.67 Million	--

pp = percentage points

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.15 Billion

CN¥7.86 Billion CNY

Market Cap Rank

#8021 Global

#1755 in China

Share Price

CN¥16.91

Change (1 day)

+0.65%

52-Week Range

CN¥14.38 - CN¥21.44

All Time High

CN¥39.94